IBEX Technologies Inc. - IBT.V

IBT.V Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
IBT.V	0	0	0.7	29.5	52.6	76.8	281.6	866.7	2316.7	-76.8
S&P 500	-1.3	-1.9	0.1	5.7	10.7	29.1	24.8	88.0	186.1	33142.5

Compare IBT.V with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	IBT.V
name	IBEX Technologies Inc.
price	1.45
changes percentage	0.6944
change	0.01
day low	1.44
day high	1.45
year high	1.45
year low	0.75
market cap	35536020
price avg 50	1.3406
price avg 200	1.1286
exchange	TSXV
volume	800
avg volume	63916
open	1.44
previous close	1.44
eps	0.15
pe	9.666667
earnings announcement	2024-06-05T00:00:00.000+0000
shares outstanding	24507600
timestamp	2024-04-04 16:16:16

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 55.0%

Overall Quarterly Financial Health: 23.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	7491739	7892487	-5.08
gross profit	5200009	5358203	-2.95
gross profit ratio	0.69	0.68	2.24
research and development expenses	670615	347403	93.04
operating expenses	3352372	3090633	8.47
interest income	360290	48109	648.90
interest expense	97862	77818	25.76
ebitda	1545120	2775269	-44.33
ebitdaratio	0.35	0.35	0.40
operating income	-1480579	2267570	-165.29
operating income ratio	-0.2	0.29	-168.79
net income	3893614	1674395	132.54
net income ratio	0.52	0.21	144.98
eps	0.16	0.07	137.39

Overall Score of Annual Income Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 7 million in 2023 from 8 million in 2022 representing a change of -5.08%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 5 million in 2023 from 5 million in 2022 representing a change of -2.95%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 3 million in 2023 from 3 million in 2022 representing a change of 8.47%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 2 million in 2023 from 3 million in 2022 representing a change of -44.33%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to -1 million in 2023 from 2 million in 2022 representing a change of -165.29%. The decrease in operating income indicates worse operational performance and decreased profitability.

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 1 million in 2023 from 0 million in 2022 representing a change of 93.04%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Net Income: Net income increased to 4 million in 2023 from 2 million in 2022 representing a change of 132.54%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.16 in 2023 from 0.16 in 2022 representing a change of 137.39%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	1922000	2058206	-6.62
gross profit	1369226	1576275	-13.14
gross profit ratio	0.71	0.77	-6.98
research and development expenses	101052	129132	-21.75
operating expenses	1212114	968219	25.19
interest income	83700	105043	-20.32
interest expense	24870	25243	-1.48
ebitda	291230	861898	-66.21
ebitdaratio	0.15	0.42	-63.82
operating income	157110	608056	-74.16
operating income ratio	0.08	0.3	-72.33
net income	49664	810279	-93.87
net income ratio	0.03	0.39	-93.44
eps	0.0	0.03	-93.92

Overall Score of Quarterly Income Statement

0.12 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 2 million in 2024Q2 from 2 million in 2024Q1 representing a change of -6.62%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 1 million in 2024Q2 from 2 million in 2024Q1 representing a change of -13.14%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of -21.75%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 0 million in 2024Q2 from 1 million in 2024Q1 representing a change of -66.21%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 0 million in 2024Q2 from 1 million in 2024Q1 representing a change of -74.16%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 0 million in 2024Q2 from 1 million in 2024Q1 representing a change of -93.87%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.0 in 2024Q2 from 0.0 in 2024Q1 representing a change of -93.92%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Operating Expenses: Operating Expenses decreased to 1 million in 2024Q2 from 1 million in 2024Q1 representing a change of 25.19%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	16831356	12974197	29.73
total liabilities	3224268	3227079	-0.09
total equity	13607088	9747118	39.60
cash and cash equivalents	8547043	7641052	11.86
short term investments	300000	0	NaN
long term investments	0	0	NaN
total current assets	10227854	9025568	13.32
total non current assets	6603502	3921629	68.39
total current liabilities	1798090	1751234	2.68
total non current liabilities	1426178	1475845	-3.37
common stock	52543063	52680158	-0.26
retained earnings	-40017307	-43910921	8.87
total debt	1639023	1624698	0.88

Overall Score of Annual Balance Sheet

0.7 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 17 million in 2023 from 13 million in 2022 representing a change of 29.73%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 3 million in 2023 from 3 million in 2022 representing a change of -0.09%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 14 million in 2023 from 10 million in 2022 representing a change of 39.6%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 9 million in 2023 from 8 million in 2022 representing a change of 11.86%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 0 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 10 million in 2023 from 9 million in 2022 representing a change of 13.32%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to -40 million in 2023 from -44 million in 2022 representing a change of 8.87%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Current Liabilities: Total Current Liabilities increased to 2 million in 2023 from 2 million in 2022 representing a change of 2.68%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 53 in 2023 from 53 in 2022 representing a change of -0.26%. This indicates a decrease in ownership interest.

  Total Debt: Total Debt increased to 2 million in 2023 from 2 million in 2022 representing a change of 0.88%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	17228411	17851124	-3.49
total liabilities	2997411	3544315	-15.43
total equity	14231000	14306809	-0.53
cash and cash equivalents	8692197	8745644	-0.61
short term investments	0	0	NaN
long term investments	0	0	NaN
total current assets	10504108	11035834	-4.82
total non current assets	6724303	6815290	-1.34
total current liabilities	1684660	2174201	-22.52
total non current liabilities	1312751	1370114	-4.19
common stock	52010388	52300282	-0.55
retained earnings	-39157364	-39207028	0.13
total debt	1573589	1639389	-4.01

Overall Score of Quarterly Balance Sheet

0.44 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 17 million in 2024Q2 from 18 million in 2024Q1 representing a change of -3.49%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 14 million in 2024Q2 from 14 million in 2024Q1 representing a change of -0.53%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 9 million in 2024Q2 from 9 million in 2024Q1 representing a change of -0.61%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 11 million in 2024Q2 from 11 million in 2024Q1 representing a change of -4.82%. This indicates a worsen liquidity position.

  Common Stock: Common Stock decreased to 52 in 2024Q2 from 52 in 2024Q1 representing a change of -0.55%. This indicates a decrease in ownership interest.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 3 million in 2024Q2 from 4 million in 2024Q1 representing a change of -15.43%. This indicates a decrease in overall liabilities.

  Total Current Liabilities: Total Current Liabilities decreased to 2 million in 2024Q2 from 2 million in 2024Q1 representing a change of -22.52%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to -39 million in 2024Q2 from -39 million in 2024Q1 representing a change of 0.13%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 2 million in 2024Q2 from 2 million in 2024Q1 representing a change of -4.01%. This indicates a reduction in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	905991	3207151	-71.75
operating cash flow	2247106	3580785	-37.25
free cash flow	1239907	3435944	-63.91
capital expenditure	-1007199	-144841	-595.38
depreciation and amortization	437055	369933	18.14
deferred income tax	-1872474	668254	-380.20
stock based compensation	8940	170991	-94.77
accounts payables	9864	634852	-98.45
inventory	56255	91482	-38.51
acquisitions net	0	0	NaN
investments in property plant and equipment	-1007199	-144841	-595.38
net cash used for investing activites	-1007199	-144841	-595.38
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-42584	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	-333916	-228793	-45.95
cash at end of period	8547043	7641052	11.86
accounts receivables	-351442	-36644	-859.07
cash at beginning of period	7641052	4433901	72.33

Overall Score of Annual Cashflow Statement

0.57 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 1 million in 2023 from 3 million in 2022 representing a change of -71.75%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 2 million in 2023 from 4 million in 2022 representing a change of -37.25%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 1 million in 2023 from 3 million in 2022 representing a change of -63.91%. This indicates a decrease in cash generated after accounting for capital expenditures.

• 📈 Positive Indicators

  Capital Expenditure: Capital Expenditure decreased to -1 million in 2023 from 0 million in 2022 representing a change of -595.38%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2023 from 0 million in 2022 representing a change of -94.77%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2023 from 1 million in 2022 representing a change of -98.45%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to 0 million in 2023 from 0 million in 2022 representing a change of -859.07%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	200379	673552	-70.25
free cash flow	157248	388653	-59.54
capital expenditure	-43131	-284899	84.86
depreciation and amortization	134118	133313	0.60
deferred income tax	-291904	0	NaN
stock based compensation	685	1262	-45.72
accounts receivables	477780	-603312	179.19
accounts payables	-481104	319681	-250.50
inventory	-19659	-63091	68.84
acquisitions net	0	0	NaN
investments in property plant and equipment	-43131	-284899	84.86
net cash used for investing activites	-43131	-284899	84.86
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-126157	-111820	-12.82
dividends paid	0	0	NaN
net cash used provided by financing activities	-210695	-190052	-10.86
net change in cash	-53447	198601	-126.91
cash at end of period	8692197	8745644	-0.61
cash at beginning of period	8745644	8547043	2.32

Overall Score of Quarterly Cashflow Statement

0.14 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of -126.91%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 0 million in 2024Q2 from 1 million in 2024Q1 representing a change of -70.25%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of -59.54%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of 84.86%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of -250.5%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 0 in 2024Q2 from -1 million in 2024Q1 representing a change of 179.19%. This suggests that the company is less capable of collecting payments from its customers.

• 📈 Positive Indicators

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of -45.72%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-07-31	2022-07-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	0.3	0.32	-4.91
net income per share	0.16	0.07	132.94
operating cash flow per share	0.09	0.14	-37.14
free cash flow per share	0.05	0.14	-63.85
cash per share	0.36	0.31	15.99
book value per share	0.55	0.39	39.84
tangible book value per share	0.55	0.39	39.46
shareholders equity per share	0.55	0.39	39.84
interest debt per share	0.07	0.07	2.20
market cap	29488172.63	10673994.92	176.26
enterprise value	22580152.63	4657640.92	384.80
pe ratio	7.57	6.37	18.80
price to sales ratio	3.94	1.35	191.04
pocfratio	13.12	2.98	340.23
pfcf ratio	23.78	3.11	665.56
pb ratio	2.17	1.1	97.89
ptb ratio	2.17	1.1	97.89
ev to sales	3.01	0.59	410.73
enterprise value over ebitda	14.61	1.68	770.77
ev to operating cash flow	10.05	1.3	672.53
ev to free cash flow	18.21	1.36	1243.44
earnings yield	0.13	0.16	-15.83
free cash flow yield	0.04	0.32	-86.94
debt to equity	0.12	0.17	-27.74
debt to assets	0.1	0.13	-22.24
net debt to ebitda	-4.47	-2.17	-106.24
current ratio	5.69	5.15	10.37
interest coverage	-15.13	29.14	-151.92
income quality	0.58	2.14	-73.01
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.09	0.04	103.36
intangibles to total assets	0.0	0	NaN
capex to operating cash flow	0.45	0.04	1008.10
capex to revenue	0.13	0.02	632.58
capex to depreciation	2.3	0.39	488.59
stock based compensation to revenue	0.0	0.02	-94.49
graham number	1.39	0.77	80.49
roic	-0.19	0.14	-233.95
return on tangible assets	0.23	0.13	79.65
graham net net	0.27	0.21	27.62
working capital	8429764	7274334	15.88
tangible asset value	13569542	9747118	39.22
net current asset value	7003586	5798489	20.78
invested capital	11910784	9945955	19.76
average receivables	1167153	973110	19.94
average payables	1580313	1257955	25.63
average inventory	199048	272916	-27.07
days sales outstanding	65.43	45.85	42.69
days payables outstanding	252.48	226.89	11.28
days of inventory on hand	27.22	32.72	-16.80
receivables turnover	5.58	7.96	-29.92
payables turnover	1.45	1.61	-10.13
inventory turnover	13.41	11.16	20.19
roe	0.29	0.17	66.57
capex per share	0.04	0.01	596.60

• Positive

  ROE: Return on Equity (ROE) increased to 0.29 on 2023-07-31 from 0.17 on 2022-07-31, representing a change of 66.57%. Suggesting the company has been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 7.57 on 2023-07-31 from 6.37 on 2022-07-31, representing a change of 18.80%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.12 on 2023-07-31 from 0.17 on 2022-07-31, representing a change of -27.74%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  Current Ratio: Current Ratio increased to 5.69 on 2023-07-31 from 5.15 on 2022-07-31, representing a change of 10.37%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Quarterly Financial Ratios

	2024-01-31 Q2	2023-10-31 Q1	Q/Q change %
IBT.V
calendar year	2024	2024	NaN
revenue per share	0.08	0.08	-6.10
net income per share	0.0	0.03	-93.84
operating cash flow per share	0.01	0.03	-70.08
free cash flow per share	0.01	0.02	-59.31
cash per share	0.35	0.35	-0.06
book value per share	0.58	0.58	0.02
tangible book value per share	0.58	0.58	0.02
shareholders equity per share	0.58	0.58	0.02
interest debt per share	0.07	0.07	-3.44
market cap	27448561.28	24644244	11.38
enterprise value	20329953.28	17537989	15.92
pe ratio	138.17	7.6	1717.18
price to sales ratio	14.28	11.97	19.27
pocfratio	136.98	36.59	274.39
pfcf ratio	174.56	63.41	175.28
pb ratio	1.93	1.72	11.97
ptb ratio	1.93	1.72	11.97
ev to sales	10.58	8.52	24.13
enterprise value over ebitda	69.81	20.35	243.06
ev to operating cash flow	101.46	26.04	289.65
ev to free cash flow	129.29	45.13	186.51
earnings yield	0.0	0.03	-94.50
free cash flow yield	0.01	0.02	-63.67
debt to equity	0.11	0.11	-3.50
debt to assets	0.09	0.09	-0.54
net debt to ebitda	-24.44	-8.24	-196.47
current ratio	6.24	5.08	22.84
interest coverage	6.32	24.09	-73.77
income quality	4.03	0.83	385.37
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.05	0.06	-16.20
intangibles to total assets	0	0	NaN
capex to operating cash flow	0.22	0.42	-49.11
capex to revenue	0.02	0.14	-83.79
capex to depreciation	0.32	2.14	-84.95
stock based compensation to revenue	0.0	0.0	-41.87
graham number	0.16	0.66	-75.17
roic	0.0	0.04	-91.23
return on tangible assets	0.0	0.05	-93.65
graham net net	0.28	0.28	2.71
working capital	8819448	8861633	-0.48
tangible asset value	14231000	14306809	-0.53
net current asset value	7506697	7491519	0.20
invested capital	12421269	12554441	-1.06
average receivables	1707296	1644530	3.82
average payables	1664374	1745085.5	-4.63
average inventory	243841	202466.5	20.44
days sales outstanding	68.76	85.1	-19.20
days payables outstanding	231.82	355.74	-34.83
days of inventory on hand	41.3	43.7	-5.49
receivables turnover	1.31	1.06	23.77
payables turnover	0.39	0.25	53.46
inventory turnover	2.18	2.06	5.81
roe	0.0	0.06	-93.84
capex per share	0.0	0.01	-84.78

• Negative

  ROE: Return on Equity (ROE) decreased to 0.00 on 2024-01-31 Q2 from 0.06 on 2023-10-31 Q1, representing a change of -93.84%. Suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 6.24 on 2024-01-31 Q2 from 5.08 on 2023-10-31 Q1, representing a change of 22.84%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 138.17 on 2024-01-31 Q2 from 7.60 on 2023-10-31 Q1, representing a change of 1717.18%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.11 on 2024-01-31 Q2 from 0.11 on 2023-10-31 Q1, representing a change of -3.50%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 2.55 which is higher than current price 1.45, indicates the company may be undervalued.